A study in healthy people to compare how 2 different low dose formulations of BI 1015550 are taken up in the body
This study is designed for healthy volunteers to help scientists understand how a new medicine, called BI 1015550, is taken up and processed by the body. Specifically, it compares two slightly different ways the medicine is made (formulations) to see if they behave the same way. This type of research, known as a 'bioequivalence study,' is a very early step in developing new medicines. It helps ensure that different versions of a drug work similarly inside the body, which is important for future testing and eventual use. Participants in this study will not be treated for an illness; instead, they are helping researchers learn vital information about the drug itself, paving the way for potential future studies in patients.
At a glance
What is this study about?
Imagine a new medicine that could help people. Before doctors can even think about using it to treat illnesses, they need to understand exactly how it works inside the human body. This particular study is an important early step in that process. It's like checking how well a new car engine runs before putting it into general use.
The study focuses on a medicine called BI 1015550. Researchers want to compare two slightly different versions, or 'formulations,' of this medicine. Think of it like comparing two different ways to package a snack – the ingredients are the same, but the packaging might affect how easily you can eat it. Similarly, different formulations of a medicine can affect how well the body takes it in.
By including healthy volunteers, scientists can carefully observe how the body absorbs, processes, and gets rid of each version of BI 1015550. This helps them confirm that the medicine is behaving as expected and provides valuable information for further research. This kind of study is crucial because it ensures that any future studies on this medicine are built on a solid understanding of how it moves through the body.
Key takeaways
- This is an early-stage study for a new medicine, BI 1015550.
- It aims to understand how the medicine is absorbed and processed by the body.
- The study compares two slightly different versions of the medicine.
- Participants must be healthy adults, aged 18 or older, male or female.
- Participation involves clinic visits, taking medicine, and blood tests.
- It helps scientists develop future treatments, but does not treat illness.
Who may be eligible?
This study is looking for healthy adults to take part. To be considered, you need to be at least 18 years old or older. There is no upper age limit, meaning people of all adult ages can potentially join.
Both men and women are welcome to participate in this study. The main requirement is that you are in generally good health and meet any other specific health checks the study team might have. These checks are in place to ensure your safety throughout the study.
During the screening process, the study team will ask you some health questions and might do some simple tests to confirm you are suitable and that participating will not put your health at risk. It's important to be open and honest about your health history.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally healthy and do not have any major ongoing illnesses?
- Are you willing to attend multiple clinic visits?
- Are you comfortable with giving blood samples?
- Are you able to follow specific instructions about food, drink, or other medications?
What does participation involve?
Taking part in this study would involve several visits to a clinic. You would be given doses of the study medicine, BI 1015550, at different times. The team would then take blood samples at specific intervals to measure how the medicine is behaving in your body. You might also have other assessments, like checking your vital signs (blood pressure, heart rate).
There might be overnight stays involved, especially when you are given the medicine, so the team can monitor you closely. You'll likely receive detailed instructions about what to eat or drink before appointments, and what medicines to avoid. After the main study period, there might be a follow-up visit or call to check on your well-being. The total duration of your involvement, including all visits and follow-ups, would be fully explained before you agree to participate.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is BI 1015550?
BI 1015550 is a new medicine that is still in early development. This study is helping scientists understand how it works in the body.
Will this study treat an illness?
No, this study is not designed to treat an illness. It's an early-stage study to gather information about the medicine itself using healthy volunteers.
What does 'bioequivalence' mean?
Bioequivalence means that two different versions (formulations) of the same medicine are absorbed by the body in the same way and at similar rates.
Do I have to stay overnight for the study?
Some parts of the study might require overnight stays in the clinic so the research team can monitor you carefully after you take the medicine. This will be fully explained to you.
Will I be paid for participating?
Many clinical studies offer some level of payment for your time and inconvenience. This will be discussed with you by the study team.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.